feed,title,long_url,short_url
Benzinga,Adagio Files $100M IPO To Take Its COVID-19 Antibody Through Commercialization In 2022,https://benzinga.com/general/biotech/21/07/22044894/adagio-files-100m-ipo-to-take-its-covid-19-antibody-through-commercialization-in-2022,https://j.mp/3xRfUS9
